Reply to P.G. Gavin et al.
Mayo Clinic, Jacksonville, FL perez.edith@mayo.edu.
Edith A
EA
Perez
Mayo Clinic, Jacksonville, FL.
E Aubrey
EA
Thompson
Mayo Clinic, Rochester, MN.
Karla V
KV
Ballman
D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000235:genetics* / Q000276:immunology*; D005260:Female; D006801:Humans; D058990:Molecular Targeted Therapy; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis*
D061067:Antibodies, Monoclonal, Humanized; D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases